Carl Zeiss Meditec (AFX) Stock Price, News & Analysis

Company Overview

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Key Stats

• Today's Range: €59.65 to €61.65
• 50-Day Range: €48.74 to €69.60
• 52-Week Range: €54.60 to €123.75
• Volume: 66,577 shs
• Average Volume: 94,405 shs
• Market Capitalization: $5.65 billion
• P/E Ratio: 32.39
• Dividend Yield: 1.82%
• Price Target: N/A
• Consensus Rating: N/A

AFX Stock Analysis - Frequently Asked Questions

How have AFX shares performed this year?

Carl Zeiss Meditec's stock was trading at €45.52 at the start of the year. Since then, AFX stock has increased by 33.1% and is now trading at €60.60.
View the best growth stocks for 2025 here.

What other stocks do shareholders of Carl Zeiss Meditec own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Carl Zeiss Meditec investors own include Intel (INTC), Meta Platforms (META), NVIDIA (NVDA), Volkswagen (VOW3), AbbVie (ABBV), Chevron (CVX) and Siemens Aktiengesellschaft (SIE).

Industry, Sector and Symbol

• Stock Exchange: ETR
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: ETR:AFX
• CIK: N/A
• Web: www.zeiss.com
• Phone: +49-3641-2200
• Fax: N/A
• Employees: 4,950
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): €1.87
• Trailing P/E Ratio: 31.96
• Forward P/E Ratio: 20.47
• P/E Growth: 2.83
• Net Income: $185.59 million
• Net Margins: 7.03%
• Pretax Margin: N/A
• Return on Equity: 8.49%
• Return on Assets: 7.03%

Debt

• Debt-to-Equity Ratio: 7.41
• Current Ratio: 2.13
• Quick Ratio: 2.47

Sales & Book Value

• Annual Sales: $2.64 billion
• Price / Sales: 2.11
• Cash Flow: €0.04 per share
• Price / Cash Flow: 1,398.28
• Book Value: €22.92 per share
• Price / Book: 2.61

Miscellaneous

• Outstanding Shares: 93,178,085
• Free Float: N/A
• Market Cap: $5.57 billion
• Optionable: Not Optionable
• Beta: 0.98